Pictet & Cie (Europe) Sa Penumbra Inc Transaction History

Pictet & Cie (Europe) Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$190.97 - $253.66 $31,701 - $42,107	-166 Reduced 13.2%	1,092 $259,000
Q3 2024 Oct 22, 2024	BUY	$163.64 - $210.12 $205,859 - $264,330	1,258 New	1,258 $244,000
Q2 2023 Aug 08, 2023	SELL	$271.54 - $344.06 $13,848 - $17,547	-51 Reduced 3.77%	1,300 $447,000
Q1 2023 May 01, 2023	BUY	$220.43 - $278.69 $297,800 - $376,510	1,351 New	1,351 $376,000

506

29.6M

241K

55.1K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.42B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.